Clinical Focus
Business Focus
Spotlight
Subscribe
CE/CME
- Adult Immunization
- Hepatology
- Pediatric Immunization
- Screening
- Psychiatry
- Allergy
- Women's Health
- Cardiology
- Pediatrics
- Dermatology
- Endocrinology
- Pain Management
- Gastroenterology
- Geriatrics
- Infectious Disease
- Obesity Medicine
- Rheumatology
- Oncology
- Nephrology
- Neurology
- Pulmonology
Navigating the New Era of Major Depressive Disorder Treatment: Expert Opinions on Rapid Acting Therapies : Episode 5
Approach to Treatment in Patients with MDD
Practitioners discuss their approach to treatment with their patients with major depressive disorder (MDD).
EP: 1.Healthcare Perception of Major Depressive Disorder
EP: 2.Undertreatment in Patients Suffering From MDD
EP: 3.Tailoring Treatments for Patients With MDD
EP: 4.MDD as a Chronic Condition
Now Viewing
EP: 5.Approach to Treatment in Patients with MDD
EP: 6.MDD Treatment: Follow-Up
EP: 7.MDD Remission
EP: 8.Treatment Switch for MDD
EP: 9.New Classes of Treatment for MDD
EP: 10.Practice Pearls for Optimizing MDD Treatment
Related Videos
Related Content
Podcast: Arthritis, Anxiety, and Depression: Managing a Common Comorbidity
May 14th 2012Podcast
Anxiety is even more common than depression among people who have arthritis, a new study has shown. Here to discuss the implications for diagnosis and treatment is Eilzabeth Lin MD, a family medicine physician who is a longstanding researcher in the field of depression and pain.
FDA Approves Esketamine as Monotherapy for Adults With Treatment-Resistant Depression
January 21st 2025Article
The approval of esketamine follows an FDA Priority Review and is based on data showing that esketamine alone demonstrated rapid and superior improvement in depressive symptoms compared with placebo.
